What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Mutation
His primary scientific interests are in Epilepsy, Pediatrics, Status epilepticus, Internal medicine and Pharmacology.
His research on Epilepsy concerns the broader Neuroscience.
Eric D. Marsh has researched Pediatrics in several fields, including Adverse effect, Randomized controlled trial and Dravet syndrome.
His studies in Dravet syndrome integrate themes in fields like Young adult, Mortality rate, Clinical endpoint, Traditional medicine and Convulsion.
The Oxidative stress research he does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Oligodendrocyte differentiation, therefore creating a link between diverse domains of science.
His Pharmacology research is multidisciplinary, incorporating elements of Missense mutation, NMDA receptor, Memantine, Prospective cohort study and Epileptic spasms.
His most cited work include:
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome (635 citations)
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial (449 citations)
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial (337 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Epilepsy, Neuroscience, Electroencephalography, Pediatrics and Epilepsy surgery.
His Epilepsy study focuses on Status epilepticus in particular.
His Neuroscience research includes elements of GABAergic and Disease.
His study in Electroencephalography is interdisciplinary in nature, drawing from both Cognition and Audiology.
His research in Pediatrics intersects with topics in Seizure types, Dravet syndrome, Natural history study, Epilepsy syndromes and Genetic testing.
His Epilepsy surgery research also works with subjects such as
- Ictal that connect with fields like Pediatric epilepsy,
- Intracranial eeg that connect with fields like Pattern recognition and Artificial intelligence.
He most often published in these fields:
- Epilepsy (66.44%)
- Neuroscience (43.84%)
- Electroencephalography (26.03%)
What were the highlights of his more recent work (between 2019-2021)?
- Rett syndrome (13.70%)
- Neurodevelopmental disorder (13.70%)
- Neuroscience (43.84%)
In recent papers he was focusing on the following fields of study:
Eric D. Marsh focuses on Rett syndrome, Neurodevelopmental disorder, Neuroscience, Epilepsy and Disease.
His Rett syndrome research also works with subjects such as
- Natural history study and related Pediatrics, MECP2 duplication syndrome, Clinical significance and Visual evoked potentials,
- CDKL5 which intersects with area such as Intellectual disability, Cortical visual impairment and Epileptic spasms,
- Cohort which connect with Clinical syndrome, Microcephaly, Bohring–Opitz syndrome and Hypotonia.
His work deals with themes such as Transcription factor and GABAergic, which intersect with Neuroscience.
His study in the field of Ictal is also linked to topics like Chemistry.
His Ictal research focuses on Epilepsy surgery and how it connects with Internal medicine.
His Disease research includes themes of Phenotype, Hypoxia, Human genetics and Bioinformatics.
Between 2019 and 2021, his most popular works were:
- Correction: The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system. (12 citations)
- Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy (11 citations)
- Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy (11 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Mutation
Eric D. Marsh mainly investigates Epilepsy, CDKL5, Rett syndrome, MECP2 and FOXG1.
His Epilepsy research is multidisciplinary, relying on both Temporal cortex, Amyloid precursor protein and Amyloid.
His CDKL5 research incorporates themes from Bioinformatics, Mutant, Intellectual disability, Neurodevelopmental disorder and Cortical visual impairment.
The study incorporates disciplines such as Seizure types, Natural history study, MECP2 duplication syndrome, Developmental regression and Pediatrics in addition to Rett syndrome.
His work focuses on many connections between MECP2 and other disciplines, such as Clinical trial, that overlap with his field of interest in Neuroscience.
His biological study deals with issues like Internal medicine, which deal with fields such as Electroencephalography.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
